日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)

植物性抗氧化剂在结直肠癌治疗中的应用潜力:挑战与展望(综述)

Fu, Daan; Fu, Haoyu; Wang, Yafeng; Yang, Kai; Nie, Bingqing; Lu, Xiaohuan

Single-cell transcriptome analysis dissects lncRNA-associated gene networks in Arabidopsis

单细胞转录组分析剖析拟南芥中的 lncRNA 相关基因网络

Zhaohui He, Yangming Lan, Xinkai Zhou, Bianjiong Yu, Tao Zhu, Fa Yang, Liang-Yu Fu, Haoyu Chao, Jiahao Wang, Rong-Xu Feng, Shimin Zuo, Wenzhi Lan, Chunli Chen, Ming Chen, Xue Zhao, Keming Hu, Dijun Chen

Spatially confined transition metals boost high initial coulombic efficiency in alloy anodes

空间受限的过渡金属可提高合金阳极的初始库仑效率

Fu, Haoyu; Gu, Fangchao; Niu, Yize; Liao, Shuxuan; Bu, Zeyuan; Wang, Haonan; Yang, Dong; Wang, Xiaoshan; Li, Qiang

Five New Species of the Genus Hymenogaster (Hymenogastraceae, Agaricales) from Northern China

中国北方五种新种伞菌属(伞菌科,伞菌目)

Li, Ting; Mao, Ning; Fu, Haoyu; Zhang, Yuxin; Fan, Li

Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells

第三代 EGFR 抑制剂 HS-10296 与多靶点酪氨酸激酶抑制剂法米替尼联合使用,可通过增强对 EGFR 突变型非小细胞肺癌细胞下游信号传导的抑制作用,发挥协同抗肿瘤作用。

Zhang, Mi; Quan, Haitian; Fu, Li; Li, Yun; Fu, Haoyu; Lou, Liguang

Early differential diagnosis model for acute radiation pneumonitis based on multiple parameters

基于多参数的急性放射性肺炎早期鉴别诊断模型

Wang, Zhiwu; Wu, Qiong; Dong, Liang; Fu, Haoyu; Liu, Qiwei

The role of procalcitonin in differential diagnosis between acute radiation pneumonitis and bacterial pneumonia in lung cancer patients receiving thoracic radiotherapy

降钙素原在肺癌患者接受胸部放射治疗后鉴别诊断急性放射性肺炎和细菌性肺炎中的作用

Wang, Zhiwu; Huo, Bingjie; Wu, Qiong; Dong, Liang; Fu, Haoyu; Wang, Shuo; Zhang, Jing

Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials

氟唑帕尼(一种正在进行临床试验的新型聚(ADP-核糖)聚合酶抑制剂)的药理学特征

Wang, Lei; Yang, Changyong; Xie, Chengying; Jiang, Jiahua; Gao, Mingzhao; Fu, Li; Li, Yun; Bao, Xubin; Fu, Haoyu; Lou, Liguang

SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met

SHR-A1403 是一种新型的 c-间质-上皮转化因子 (c-Met) 抗体-药物偶联物,可克服过表达 c-Met 的非小细胞肺癌细胞对 AZD9291 的耐药性。

Tong, Mengya; Gao, Mingzhao; Xu, Yongping; Fu, Li; Li, Yun; Bao, Xubin; Fu, Haoyu; Quan, Haitian; Lou, Liguang

Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models.

在体外和人类肿瘤异种移植模型中对新型 CDK 4/6 抑制剂 SHR6390 进行临床前表征

Long Fei, He Ye, Fu Haoyu, Li Yun, Bao Xubin, Wang Quanren, Wang Yigang, Xie Chengying, Lou Liguang